BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 7, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 29, 2010
View Archived Issues
'Peer Esteem' is Key Factor in Predicting Nobel Winners
Read More
Newco News: Excelimmune Aims Polyclonal Antibodies at Bacterial Disease
Read More
Researcher's Pet Project Leads to Eye Therapy, Lasker Prize
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Prostate Cancer Takes Hit with Pfizer, AstraZeneca Failures
The prostate cancer therapy arena was dealt two blows this week, with Pfizer Inc.'s Sutent (sunitinib malate) and AstraZeneca plc's zibotentan both failing to demonstrate an improvement in overall survival. (BioWorld Today)
Read More
Sanofi-Aventis Grabs Pieris' Protein Therapy Platform
Read More
Financings Roundup
Read More
